Evariste is an AI-enabled drug discovery company developing small molecule inhibitors of next generation synthetic lethality targets. Using our automated AI-enabled drug discovery platform, Frobenius, we are able to progress preclinical drug discovery projects at scale and with unparalleled efficiency.